Psomagen Statistics

Total Valuation

Psomagen has a market cap or net worth of KRW 69.06 billion. The enterprise value is 70.36 billion.

Market Cap	69.06B
Enterprise Value	70.36B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Psomagen has 19.24 million shares outstanding. The number of shares has increased by 15.45% in one year.

Current Share Class	n/a
Shares Outstanding	19.24M
Shares Change (YoY)	+15.45%
Shares Change (QoQ)	+26.49%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	n/a
Float	8.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.23
PB Ratio	2.73
P/TBV Ratio	3.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.02, with an EV/FCF ratio of -15.73.

EV / Earnings	-16.75
EV / Sales	1.26
EV / EBITDA	27.02
EV / EBIT	n/a
EV / FCF	-15.73

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.53.

Current Ratio	1.48
Quick Ratio	1.01
Debt / Equity	0.53
Debt / EBITDA	4.55
Debt / FCF	-2.98
Interest Coverage	-5.28

Financial Efficiency

Return on equity (ROE) is -19.57% and return on invested capital (ROIC) is -4.34%.

Return on Equity (ROE)	-19.57%
Return on Assets (ROA)	-3.03%
Return on Invested Capital (ROIC)	-4.34%
Return on Capital Employed (ROCE)	-7.85%
Revenue Per Employee	658.58M
Profits Per Employee	-49.42M
Employee Count	89
Asset Turnover	1.02
Inventory Turnover	6.03

Taxes

Income Tax	-26.80M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.93% in the last 52 weeks. The beta is -0.39, so Psomagen's price volatility has been lower than the market average.

Beta (5Y)	-0.39
52-Week Price Change	-14.93%
50-Day Moving Average	3,589.30
200-Day Moving Average	3,733.38
Relative Strength Index (RSI)	50.96
Average Volume (20 Days)	25,192

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Psomagen had revenue of KRW 55.98 billion and -4.20 billion in losses. Loss per share was -208.58.

Revenue	55.98B
Gross Profit	13.47B
Operating Income	-2.66B
Pretax Income	-5.29B
Net Income	-4.20B
EBITDA	2.93B
EBIT	-2.66B
Loss Per Share	-208.58

Full Income Statement

Balance Sheet

The company has 10.70 billion in cash and 13.33 billion in debt, giving a net cash position of -2.64 billion or -137.11 per share.

Cash & Cash Equivalents	10.70B
Total Debt	13.33B
Net Cash	-2.64B
Net Cash Per Share	-137.11
Equity (Book Value)	25.26B
Book Value Per Share	1,215.27
Working Capital	9.36B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.11 billion and capital expenditures -3.37 billion, giving a free cash flow of -4.47 billion.

Operating Cash Flow	-1.11B
Capital Expenditures	-3.37B
Free Cash Flow	-4.47B
FCF Per Share	-232.53

Full Cash Flow Statement

Margins

Gross margin is 24.07%, with operating and profit margins of -4.75% and -7.50%.

Gross Margin	24.07%
Operating Margin	-4.75%
Pretax Margin	-9.45%
Profit Margin	-7.50%
EBITDA Margin	5.23%
EBIT Margin	-4.75%
FCF Margin	n/a

Dividends & Yields

Psomagen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.45%
Shareholder Yield	-15.45%
Earnings Yield	-6.08%
FCF Yield	-6.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Psomagen has an Altman Z-Score of 0.42 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.42
Piotroski F-Score	4